APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop

Neuropathol Appl Neurobiol. 2019 Feb;45(2):183-186. doi: 10.1111/nan.12474. Epub 2018 Mar 1.

C E Murray¹, A King^{2

3}, C Troakes^{3

4}, A Hodges⁵, T Lashley¹

¹ Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
² Department of Clinical Neuropathology, Kings College Hospital, London, UK.
³ London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK.
⁴ Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.
⁵ Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

No abstract available

Publication types